All of WSIPP's research is published on our website. The Publications page includes every report we've released—from our founding in 1983 to the present. Each report entry includes the title, publication date, abstract, any available supplemental materials, and a downloadable PDF.
WSIPP reports are not updated after publication, and any report older than two years is designated with an “Archived” label.
To explore our benefit-cost and meta-analytic findings, please visit the Benefit-Cost section of the website.
Use the search fields below to find specific publications that match certain criteria. If you want to find other information on our website that is not publications, you can use the search field in the navigation bar at the top, or click here to search the entire website.
Found 1 results
Initiative 502, passed by Washington voters in November 2012, legalized the limited adult possession and private consumption of cannabis, as well as its licensed production and sale. The initiative directs WSIPP to evaluate the impact of the law in a series of reports between 2015 and 2032.
In this second required report we address preliminary findings from analyses of effects of I-502 on non-monetary outcomes. We used two main analysis strategies. We examined the effect of I-502 enactment on cannabis abuse treatment admissions, comparing Washington to similar non-legalizing states before and after I-502 enactment. We also examined how local differences in the amount of legal cannabis sales affected cannabis abuse treatment admissions, youth and adult substance use, and drug-related criminal convictions.
These analyses represent an intermediate step towards the ultimate benefit-cost evaluation of I-502 that is required by the law.